Rushad Patell (@rushadpatell) 's Twitter Profile
Rushad Patell

@rushadpatell

ID: 2460056347

calendar_today23-04-2014 17:45:42

152 Tweet

287 Followers

207 Following

Leslie L. Lake (@lesllake) 's Twitter Profile Photo

What a momentous day for the #VTE patient community!! Congrats to NBCA & to Corewell Health for receiving this groundbreaking designation! May this be a meaningful step forward in closing the gaps so many patients experience #NBCAVTECOE

Leslie L. Lake (@lesllake) 's Twitter Profile Photo

Totally agree 👍with this 👇time for policy makers to come together and fund #VTE prevention, awareness and education so we can #stoptheclot NBCA

Ajay Major, MD, MBA (@majorajay) 's Twitter Profile Photo

Check out our special #PrideMonth episode of Hematopoiesis, a podcast produced by the ASH Trainee Council, in which Drs. Emily Liang, Michael Hochman, Shail Maingi, MD and I discuss the changing landscape of career for #LGBTQ+ trainees. #meded 🏳️‍🌈🏳️‍⚧️ podcasts.apple.com/us/podcast/cel…

Check out our special #PrideMonth episode of Hematopoiesis, a podcast produced by the <a href="/ASH_hematology/">ASH</a> Trainee Council, in which Drs. <a href="/emilyliangmd/">Emily Liang</a>, <a href="/mjhochman/">Michael Hochman</a>, <a href="/shail_maingi/">Shail Maingi, MD</a> and I discuss the changing landscape of career for #LGBTQ+ trainees. #meded 🏳️‍🌈🏳️‍⚧️
podcasts.apple.com/us/podcast/cel…
Marc Carrier (@marccarrier1) 's Twitter Profile Photo

From veins to brains: Shifting paradigm in Cancer Associated Thrombosis. Strokes are common just before or right after cancer diagnosis. Cancer types, prior history of stroke and tumor stage are important predictors of CVA. More studies are needed. #ICTHIC2024

From veins to brains: Shifting paradigm in Cancer Associated Thrombosis. 

Strokes are common just before or right after cancer diagnosis. Cancer types, prior history of stroke and tumor stage are important predictors of CVA. More studies are needed. #ICTHIC2024
Deepa Rangachari (@deeparangachari) 's Twitter Profile Photo

ASCO OncMedEdCoP A career as an academic oncologist devoted to #MedEd means finding my path to contributing deeply, meaningfully to the lives of our patients and the broader community. One trainee… One training program… and through collaborative #MindfulMentorship, around the World!

Thita Joy Chiasakul (@joythitac) 's Twitter Profile Photo

Thank you @ISTH for the opportunity. Looking forward to all the scientific contents, career development, and networking opportunities at #ISTH2024 in our beautiful capital city!

Deepa Rangachari (@deeparangachari) 's Twitter Profile Photo

Kudos to Dr. Anthony Iacoviello for his masterful presentation of our ⁦BIDMC Hematology/Oncology Fellowship #MedEd team’s⁩ innovative, evidence-based efforts to maximize near-peer teaching & goal-concordant training. You make us proud! ⁦BIDMC IM Residency⁩ ⁦Rushad Patell⁩ ⁦Jonathan Berry

Kudos to Dr. Anthony Iacoviello for his masterful presentation of our ⁦<a href="/BIDMC_HOFellows/">BIDMC Hematology/Oncology Fellowship</a> #MedEd team’s⁩ innovative, evidence-based efforts to maximize near-peer teaching &amp; goal-concordant training. You make us proud! ⁦<a href="/BIDMC_IM/">BIDMC IM Residency</a>⁩ ⁦<a href="/rushadpatell/">Rushad Patell</a>⁩ ⁦<a href="/jlberrymd/">Jonathan Berry</a>⁩
Nathan Connell, MD, MPH (@ntconnell) 's Twitter Profile Photo

This Inside Blood Journal commentary from Ming Y Lim 明林 and Yazan Abou-Ismail, MD - د. يزن أبواسماعيل is succinct and provides great context for the published work by Ryu and colleagues examining double-heterozygous carriers of Factor V Leiden and prothrombin G20210A mutations in the FinnGen and the UK Biobank

Marc Carrier (@marccarrier1) 's Twitter Profile Photo

Dr. Nicola Potere reported that 15.5% of patients with distal DVT had recurrence following anticoagulation discontinuation. Patients with unprovoked events or diabetes and those only receiving 6 weeks of anticoagulation, are at higher risk of recurrent events! #ISTH2024

Dr. <a href="/NicolaPotereMD/">Nicola Potere</a> reported that 15.5% of patients with distal DVT had recurrence following anticoagulation discontinuation. Patients with unprovoked events or diabetes and those only receiving 6 weeks of anticoagulation, are at higher risk of recurrent events! #ISTH2024
Deepa Rangachari (@deeparangachari) 's Twitter Profile Photo

Delighted to welcome these 7 brilliant, compassionate, and ambitious humans and physicians to our ⁦BIDMC Hematology/Oncology Fellowship⁩ community! We look forward to the journey ahead with all of you. ⁦BIDMC Department of Medicine⁩ ⁦Rushad Patell

Delighted to welcome these 7 brilliant, compassionate, and ambitious humans and physicians to our ⁦<a href="/BIDMC_HOFellows/">BIDMC Hematology/Oncology Fellowship</a>⁩ community! We look forward to the journey ahead with all of you. ⁦<a href="/BIDMC_Medicine/">BIDMC Department of Medicine</a>⁩ ⁦<a href="/rushadpatell/">Rushad Patell</a>⁩